ID   DHRS4_HUMAN             Reviewed;         278 AA.
AC   Q9BTZ2; B2RB10; B7WNS9; D3YTB8; E2QRL8; O95162; Q20CR0; Q2LC19;
AC   Q2LE81; Q58IU4; Q6E0Y1; Q6UWU3; Q71UQ6; Q8TD03; Q9H3N5; Q9NV08;
DT   10-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   10-MAY-2017, entry version 152.
DE   RecName: Full=Dehydrogenase/reductase SDR family member 4;
DE            EC=1.1.1.184;
DE   AltName: Full=NADPH-dependent carbonyl reductase/NADP-retinol dehydrogenase;
DE            Short=CR;
DE            Short=PHCR;
DE   AltName: Full=NADPH-dependent retinol dehydrogenase/reductase;
DE            Short=NRDR;
DE            Short=humNRDR;
DE   AltName: Full=Peroxisomal short-chain alcohol dehydrogenase;
DE            Short=PSCD;
DE   AltName: Full=SCAD-SRL;
DE   AltName: Full=Short chain dehydrogenase/reductase family 25C member 2;
DE   AltName: Full=Short-chain dehydrogenase/reductase family member 4;
GN   Name=DHRS4; Synonyms=SDR25C2; ORFNames=UNQ851/PRO1800;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=10333503; DOI=10.1042/bj3400561;
RA   Fransen M., Van Veldhoven P.P., Subramani S.;
RT   "Identification of peroxisomal proteins by using M13 phage protein VI
RT   phage display: molecular evidence that mammalian peroxisomes contain a
RT   2,4-dienoyl-CoA reductase.";
RL   Biochem. J. 340:561-568(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Furukawa A., Ohnishi T., Huang D., Araki N., Ichikawa Y.;
RT   "cDNA cloning and characterization of peroxisomal short-chain
RT   dehydrogenase / reductase that reduces all-trans retinal to retinol.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RX   PubMed=15473316;
RA   Du J., Huang D.-Y., Liu G.-F., Wang G.-L., Xu X.-L., Wang B., Zhu L.;
RT   "cDNA cloning of a short isoform of human liver NADP (H) -dependent
RT   retinol dehydrogenase/reductase and analysis of its characteristics.";
RL   Yi Chuan Xue Bao 31:661-667(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Tu Q., Yu L., Bi A., Li N., He W., Zhao S.;
RT   "Molecular cloning and expression analysis of a novel human cDNA
RT   encoding a protein homologous to human Hep27 protein.";
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7).
RA   Li Y.F., Liu G.-F., Song X.-H., Yang Y.M., Zhong J.C., Du K., Zhu W.,
RA   Huang D.-Y.;
RT   "A minor misassignment error inside segmental duplication (MMEISD) of
RT   DHRS4 gene in human genome sequence.";
RL   Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Li Y.F., Liu G.-F., Song X.-H., Du K., Huang D.-Y.;
RT   "cDNA cloning of a short isoform of human neuroblastoma NADP(H)-
RT   dependent retinol dehydrogenase/reductase and analysis of its
RT   characteristics.";
RL   Ai Bian Ji Bian Tu Bian 17:321-326(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), NUCLEOTIDE SEQUENCE [MRNA]
RP   (ISOFORM 6), NUCLEOTIDE SEQUENCE [MRNA] OF 40-278 (ISOFORM 5),
RP   SUBCELLULAR LOCATION (ISOFORM 4), AND TISSUE SPECIFICITY (ISOFORM 4).
RC   TISSUE=Cervix carcinoma, and Neuroblastoma;
RX   PubMed=17230527; DOI=10.1002/ijc.22306;
RA   Song X.-H., Liang B., Liu G.-F., Li R., Xie J.-P., Du K., Huang D.-Y.;
RT   "Expression of a novel alternatively spliced variant of NADP(H)-
RT   dependent retinol dehydrogenase/reductase with deletion of exon 3 in
RT   cervical squamous carcinoma.";
RL   Int. J. Cancer 120:1618-1626(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta, and Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140 (ISOFORM 5), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   ALTERNATIVE SPLICING (ISOFORM 8).
RX   PubMed=23128527; DOI=10.1159/000343326;
RA   Yan Y., Song X., Liu G., Su Z., Du Y., Sui X., Chang X., Huang D.;
RT   "Human NRDRB1, an alternatively spliced isoform of NADP(H)-dependent
RT   retinol dehydrogenase/reductase enhanced enzymatic activity of
RT   Benzil.";
RL   Cell. Physiol. Biochem. 30:1371-1382(2012).
RN   [15]
RP   SUBCELLULAR LOCATION (ISOFORM 7).
RX   PubMed=22227495; DOI=10.1016/j.gene.2011.12.033;
RA   Su Z., Li R., Song X., Liu G., Li Y., Chang X., Li C., Huang D.;
RT   "Identification of a novel isoform of DHRS4 protein with a nuclear
RT   localization signal.";
RL   Gene 494:161-167(2012).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Reduces all-trans-retinal and 9-cis retinal. Can also
CC       catalyze the oxidation of all-trans-retinol with NADP as co-
CC       factor, but with much lower efficiency. Reduces alkyl phenyl
CC       ketones and alpha-dicarbonyl compounds with aromatic rings, such
CC       as pyrimidine-4-aldehyde, 3-benzoylpyridine, 4-benzoylpyridine,
CC       menadione and 4-hexanoylpyridine. Has no activity towards
CC       aliphatic aldehydes and ketones (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: R-CHOH-R' + NADP(+) = R-CO-R' + NADPH.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Peroxisome {ECO:0000269|PubMed:10333503}.
CC       Note=Isoform 1 is peroxisomal, while isoform 4 is not.
CC   -!- SUBCELLULAR LOCATION: Isoform 7: Nucleus
CC       {ECO:0000269|PubMed:22227495}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=1; Synonyms=SDR-SRL3;
CC         IsoId=Q9BTZ2-1; Sequence=Displayed;
CC       Name=2; Synonyms=SDR-SRL1;
CC         IsoId=Q9BTZ2-2; Sequence=VSP_008586;
CC       Name=3; Synonyms=SDR-SRL2;
CC         IsoId=Q9BTZ2-3; Sequence=VSP_008585;
CC       Name=4; Synonyms=NRDRB1;
CC         IsoId=Q9BTZ2-4; Sequence=VSP_031436;
CC       Name=5; Synonyms=NRDRB2;
CC         IsoId=Q9BTZ2-5; Sequence=VSP_031436, VSP_031438;
CC         Note=Contains a phosphoserine at position 140.
CC         {ECO:0000244|PubMed:18669648};
CC       Name=6; Synonyms=DHRS4L2, NRDRA1;
CC         IsoId=Q9BTZ2-6; Sequence=VSP_031435;
CC       Name=7; Synonyms=NRDRA2;
CC         IsoId=Q9BTZ2-7; Sequence=VSP_031437, VSP_031439;
CC         Note=Mainly localized in the nucleus.;
CC       Name=8; Synonyms=NRDRB1;
CC         IsoId=Q9BTZ2-8; Sequence=VSP_044947, VSP_031436;
CC         Note=Enhanced dicarbonyl reductase activity. high expression in
CC         liver.;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is predominantly expressed in normal
CC       cervix (at protein level). Isoform 4 is expressed in some
CC       neoplastic cervical tissues, but not in normal cervix (at protein
CC       level). Isoform 5 and isoform 6 are expressed in a few neoplastic
CC       cervical tissues.
CC   -!- MISCELLANEOUS: Inhibited by kaempferol, quercetin, genistein and
CC       myristic acid. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases
CC       (SDR) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD02292.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAL61824.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB18775.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAG37057.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF044127; AAD02292.1; ALT_INIT; mRNA.
DR   EMBL; AB045131; BAB18775.1; ALT_INIT; mRNA.
DR   EMBL; AY071856; AAL61824.2; ALT_INIT; mRNA.
DR   EMBL; AF064256; AAQ13444.1; -; mRNA.
DR   EMBL; AY616182; AAT70757.1; -; mRNA.
DR   EMBL; DQ344810; ABD75823.1; -; mRNA.
DR   EMBL; AY943857; AAX49568.1; -; mRNA.
DR   EMBL; DQ325464; ABC61320.1; -; mRNA.
DR   EMBL; DQ338571; ABC61321.1; -; mRNA.
DR   EMBL; AK001870; BAA91953.1; -; mRNA.
DR   EMBL; AK314448; BAG37057.1; ALT_INIT; mRNA.
DR   EMBL; AY358638; AAQ89001.1; -; mRNA.
DR   EMBL; AL136419; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC003019; AAH03019.1; -; mRNA.
DR   CCDS; CCDS61408.1; -. [Q9BTZ2-7]
DR   CCDS; CCDS61409.1; -. [Q9BTZ2-2]
DR   CCDS; CCDS61410.1; -. [Q9BTZ2-4]
DR   CCDS; CCDS61411.1; -. [Q9BTZ2-5]
DR   CCDS; CCDS61412.1; -. [Q9BTZ2-3]
DR   CCDS; CCDS9605.1; -. [Q9BTZ2-1]
DR   RefSeq; NP_001269916.1; NM_001282987.1. [Q9BTZ2-7]
DR   RefSeq; NP_001269917.1; NM_001282988.1. [Q9BTZ2-4]
DR   RefSeq; NP_001269918.1; NM_001282989.1. [Q9BTZ2-2]
DR   RefSeq; NP_001269919.1; NM_001282990.1. [Q9BTZ2-5]
DR   RefSeq; NP_001269920.1; NM_001282991.1. [Q9BTZ2-3]
DR   RefSeq; NP_066284.2; NM_021004.3. [Q9BTZ2-1]
DR   UniGene; Hs.528385; -.
DR   UniGene; Hs.743442; -.
DR   PDB; 3O4R; X-ray; 1.70 A; A/B/C/D=19-278.
DR   PDBsum; 3O4R; -.
DR   ProteinModelPortal; Q9BTZ2; -.
DR   SMR; Q9BTZ2; -.
DR   BioGrid; 116107; 49.
DR   IntAct; Q9BTZ2; 2.
DR   STRING; 9606.ENSP00000326219; -.
DR   DrugBank; DB00162; Vitamin A.
DR   iPTMnet; Q9BTZ2; -.
DR   PhosphoSitePlus; Q9BTZ2; -.
DR   BioMuta; DHRS4; -.
DR   DMDM; 308153604; -.
DR   EPD; Q9BTZ2; -.
DR   MaxQB; Q9BTZ2; -.
DR   PaxDb; Q9BTZ2; -.
DR   PeptideAtlas; Q9BTZ2; -.
DR   PRIDE; Q9BTZ2; -.
DR   Ensembl; ENST00000313250; ENSP00000326219; ENSG00000157326. [Q9BTZ2-1]
DR   Ensembl; ENST00000397074; ENSP00000380264; ENSG00000157326. [Q9BTZ2-3]
DR   Ensembl; ENST00000397075; ENSP00000380265; ENSG00000157326. [Q9BTZ2-2]
DR   Ensembl; ENST00000558263; ENSP00000453367; ENSG00000157326. [Q9BTZ2-7]
DR   Ensembl; ENST00000558581; ENSP00000452645; ENSG00000157326. [Q9BTZ2-4]
DR   Ensembl; ENST00000559632; ENSP00000453983; ENSG00000157326. [Q9BTZ2-5]
DR   GeneID; 10901; -.
DR   KEGG; hsa:10901; -.
DR   UCSC; uc001wla.5; human. [Q9BTZ2-1]
DR   CTD; 10901; -.
DR   DisGeNET; 10901; -.
DR   GeneCards; DHRS4; -.
DR   HGNC; HGNC:16985; DHRS4.
DR   HPA; HPA023972; -.
DR   MIM; 611596; gene.
DR   neXtProt; NX_Q9BTZ2; -.
DR   OpenTargets; ENSG00000157326; -.
DR   PharmGKB; PA128395792; -.
DR   eggNOG; KOG0725; Eukaryota.
DR   eggNOG; COG1028; LUCA.
DR   GeneTree; ENSGT00760000118868; -.
DR   HOVERGEN; HBG105779; -.
DR   InParanoid; Q9BTZ2; -.
DR   KO; K11147; -.
DR   OMA; LWMDKAR; -.
DR   OrthoDB; EOG091G0G3R; -.
DR   PhylomeDB; Q9BTZ2; -.
DR   TreeFam; TF315405; -.
DR   BRENDA; 1.1.1.300; 2681.
DR   Reactome; R-HSA-5365859; RA biosynthesis pathway.
DR   EvolutionaryTrace; Q9BTZ2; -.
DR   GeneWiki; DHRS4; -.
DR   GenomeRNAi; 10901; -.
DR   PRO; PR:Q9BTZ2; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000157326; -.
DR   ExpressionAtlas; Q9BTZ2; baseline and differential.
DR   Genevisible; Q9BTZ2; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005778; C:peroxisomal membrane; IDA:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0000253; F:3-keto sterol reductase activity; IDA:UniProtKB.
DR   GO; GO:0018455; F:alcohol dehydrogenase [NAD(P)+] activity; IDA:UniProtKB.
DR   GO; GO:0004090; F:carbonyl reductase (NADPH) activity; IDA:UniProtKB.
DR   GO; GO:0052650; F:NADP-retinol dehydrogenase activity; TAS:Reactome.
DR   GO; GO:0016655; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; IDA:UniProtKB.
DR   GO; GO:0005102; F:receptor binding; IPI:UniProtKB.
DR   GO; GO:0006066; P:alcohol metabolic process; IDA:UniProtKB.
DR   GO; GO:0042180; P:cellular ketone metabolic process; IDA:UniProtKB.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:UniProtKB.
DR   GO; GO:0051262; P:protein tetramerization; IDA:UniProtKB.
DR   GO; GO:0008202; P:steroid metabolic process; IDA:UniProtKB.
DR   InterPro; IPR029511; DHRS4-like.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   PANTHER; PTHR42760:SF3; PTHR42760:SF3; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   NADP; Nucleus; Oxidoreductase; Peroxisome; Phosphoprotein;
KW   Polymorphism; Reference proteome.
FT   CHAIN         1    278       Dehydrogenase/reductase SDR family member
FT                                4.
FT                                /FTId=PRO_0000054647.
FT   NP_BIND      36     60       NADP. {ECO:0000250}.
FT   MOTIF       276    278       Microbody targeting signal.
FT   ACT_SITE    182    182       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10001}.
FT   BINDING     169    169       Substrate. {ECO:0000250}.
FT   MOD_RES      92     92       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99LB2}.
FT   MOD_RES      92     92       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99LB2}.
FT   MOD_RES     105    105       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99LB2}.
FT   MOD_RES     216    216       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99LB2}.
FT   MOD_RES     216    216       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99LB2}.
FT   MOD_RES     220    220       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q99LB2}.
FT   MOD_RES     227    227       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99LB2}.
FT   MOD_RES     234    234       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99LB2}.
FT   VAR_SEQ       1     18       Missing (in isoform 8). {ECO:0000305}.
FT                                /FTId=VSP_044947.
FT   VAR_SEQ      19    221       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:17230527}.
FT                                /FTId=VSP_031435.
FT   VAR_SEQ     103    222       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10333503}.
FT                                /FTId=VSP_008585.
FT   VAR_SEQ     103    136       Missing (in isoform 4, isoform 5 and
FT                                isoform 8).
FT                                {ECO:0000303|PubMed:17230527}.
FT                                /FTId=VSP_031436.
FT   VAR_SEQ     137    222       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10333503,
FT                                ECO:0000303|PubMed:15473316}.
FT                                /FTId=VSP_008586.
FT   VAR_SEQ     137    188       TLDINVKAPALMTKAVVPEMEKRGGGSVVIVSSIAAFSPSP
FT                                GFSPYNVSKTA -> RRLSGDRVFHSSLQSISSLDGQGKRG
FT                                KHERNPADKKVRRARGLCWHRVFPVL (in isoform
FT                                7). {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_031437.
FT   VAR_SEQ     178    222       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:17230527}.
FT                                /FTId=VSP_031438.
FT   VAR_SEQ     189    278       Missing (in isoform 7).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_031439.
FT   VARIANT      31     31       A -> T (in dbSNP:rs1043442).
FT                                /FTId=VAR_057272.
FT   VARIANT     202    202       P -> S (in dbSNP:rs1043650).
FT                                /FTId=VAR_061846.
FT   CONFLICT     37     37       V -> A (in Ref. 8; BAA91953).
FT                                {ECO:0000305}.
FT   CONFLICT     50     50       R -> W (in Ref. 7; ABC61321).
FT                                {ECO:0000305}.
FT   CONFLICT     89     89       H -> M (in Ref. 4; AAQ13444).
FT                                {ECO:0000305}.
FT   CONFLICT    102    102       T -> M (in Ref. 1; AAD02292).
FT                                {ECO:0000305}.
FT   CONFLICT    126    126       I -> L (in Ref. 1; AAD02292).
FT                                {ECO:0000305}.
FT   TURN         29     32       {ECO:0000244|PDB:3O4R}.
FT   STRAND       34     39       {ECO:0000244|PDB:3O4R}.
FT   HELIX        43     54       {ECO:0000244|PDB:3O4R}.
FT   STRAND       58     64       {ECO:0000244|PDB:3O4R}.
FT   HELIX        66     78       {ECO:0000244|PDB:3O4R}.
FT   STRAND       83     87       {ECO:0000244|PDB:3O4R}.
FT   HELIX        93    107       {ECO:0000244|PDB:3O4R}.
FT   STRAND      112    115       {ECO:0000244|PDB:3O4R}.
FT   TURN        126    128       {ECO:0000244|PDB:3O4R}.
FT   HELIX       131    141       {ECO:0000244|PDB:3O4R}.
FT   HELIX       143    158       {ECO:0000244|PDB:3O4R}.
FT   STRAND      162    167       {ECO:0000244|PDB:3O4R}.
FT   HELIX       170    172       {ECO:0000244|PDB:3O4R}.
FT   HELIX       180    200       {ECO:0000244|PDB:3O4R}.
FT   HELIX       201    203       {ECO:0000244|PDB:3O4R}.
FT   STRAND      205    212       {ECO:0000244|PDB:3O4R}.
FT   HELIX       221    223       {ECO:0000244|PDB:3O4R}.
FT   HELIX       227    237       {ECO:0000244|PDB:3O4R}.
FT   HELIX       245    248       {ECO:0000244|PDB:3O4R}.
FT   HELIX       249    255       {ECO:0000244|PDB:3O4R}.
FT   HELIX       258    260       {ECO:0000244|PDB:3O4R}.
FT   STRAND      267    271       {ECO:0000244|PDB:3O4R}.
SQ   SEQUENCE   278 AA;  29537 MW;  3B06A229E1BBE47B CRC64;
     MHKAGLLGLC ARAWNSVRMA SSGMTRRDPL ANKVALVTAS TDGIGFAIAR RLAQDGAHVV
     VSSRKQQNVD QAVATLQGEG LSVTGTVCHV GKAEDRERLV ATAVKLHGGI DILVSNAAVN
     PFFGSIMDVT EEVWDKTLDI NVKAPALMTK AVVPEMEKRG GGSVVIVSSI AAFSPSPGFS
     PYNVSKTALL GLTKTLAIEL APRNIRVNCL APGLIKTSFS RMLWMDKEKE ESMKETLRIR
     RLGEPEDCAG IVSFLCSEDA SYITGETVVV GGGTPSRL
//
